Table 2 Indications of positron emission tomography
|  | AZ group (n = 263) | M group (n = 310) | p-value |
|---|---|---|---|
Lung cancer | 120 (46%) | 137 (44%) | 0.74 |
Hematologic malignancy | 54 (21%) | 61 (20%) | 0.81 |
Colorectal malignancy | 22 (8%) | 24 (8%) | 0.76 |
Upper GI malignancy | 15 (6%) | 24 (8%) | 0.34 |
Head and neck cancer | 14 (5%) | 17 (6%) | 0.92 |
Hepatobiliary-pancreatic cancer | 8 (3%) | 9 (3%) | 0.94 |
Breast cancer | 7 (3%) | 6 (2%) | 0.52 |
Other cancers | 15 (6%) | 24 (8%) | 0.34 |
Cancer survey | 6 (2%) | 4 (1%) | 0.37 |
Non-oncologic condition | 2 (1%) | 4 (1%) | 0.56 |